Medical Properties Trust Q2 loss narrows, helped by asset sales, Infracore IPO proceeds

Medical Properties Trust

10/08/2026 13:15

Overview
US hospital real estate trust's Q2 revenue rose and beat analyst expectations
Q2 net loss narrowed, with loss per share reducing to $0.01 per share from $0.16 a year earlier
Company announced $2.4 bln refinancing to extend debt maturities and asset sales for cash proceeds

Outlook
Company expects $172 mln in cash proceeds from asset sales in Q3 2026
Medical Properties Trust expects to receive an additional $35 mln from Infracore IPO proceeds in Q3
Company says it will continue to evaluate opportunities to fortify its balance sheet and pursue growth

Result Drivers
REFINANCING TRANSACTION - Co said $2.4 bln refinancing significantly extends debt maturities and reduces near-term refinancing risk
ASSET SALES AND CASH PROCEEDS - Co cited asset sales and proceeds from Infracore IPO as drivers of increased liquidity
LEASE RESTRUCTURING AND TENANT DIVERSIFICATION - Co combined Lifepoint leases and exchanged properties to increase diversification and enhance credit profile

Company press release: ID:nBw7sKNxsa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$259.28 mln
$250.88 mln (5 Analysts)
Q2 Net Loss
 
$2.29 mln
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and 3 "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy."
Wall Street's median 12-month price target for Medical Properties Trust Inc is $5.00, about 6.4% above its August 7 closing price of $4.70
The stock recently traded at 38 times the next 12-month earnings vs. a P/E of 46 three months ago

Reuters Recommended Reads
Aug 10 - Surgery Partners Q2 revenue beats on growth in same-facility segment
Aug 10 - Accendra Health Q2 profit, revenue miss estimates on large payor exit
Aug 10 - Sonida Senior Living Q2 same-store NOI rises 

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)